839 related articles for article (PubMed ID: 22057829)
21. Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease.
Schulze-Neick I; Hartenstein P; Li J; Stiller B; Nagdyman N; Hübler M; Butrous G; Petros A; Lange P; Redington AN
Circulation; 2003 Sep; 108 Suppl 1():II167-73. PubMed ID: 12970227
[TBL] [Abstract][Full Text] [Related]
22. Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide.
Michelakis E; Tymchak W; Lien D; Webster L; Hashimoto K; Archer S
Circulation; 2002 May; 105(20):2398-403. PubMed ID: 12021227
[TBL] [Abstract][Full Text] [Related]
23. Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial.
Ghofrani HA; Wiedemann R; Rose F; Schermuly RT; Olschewski H; Weissmann N; Gunther A; Walmrath D; Seeger W; Grimminger F
Lancet; 2002 Sep; 360(9337):895-900. PubMed ID: 12354470
[TBL] [Abstract][Full Text] [Related]
24. Inhaled nitric oxide versus intravenous vasodilators in severe pulmonary hypertension after cardiac surgery.
Schmid ER; Bürki C; Engel MH; Schmidlin D; Tornic M; Seifert B
Anesth Analg; 1999 Nov; 89(5):1108-15. PubMed ID: 10553820
[TBL] [Abstract][Full Text] [Related]
25. Effect of oral sildenafil citrate on intraoperative hemodynamics in patients with pulmonary hypertension undergoing valvular heart surgery.
Shim JK; Choi YS; Oh YJ; Kim DH; Hong YW; Kwak YL
J Thorac Cardiovasc Surg; 2006 Dec; 132(6):1420-5. PubMed ID: 17140970
[TBL] [Abstract][Full Text] [Related]
26. Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition.
Botha P; Parry G; Dark JH; Macgowan GA
J Heart Lung Transplant; 2009 Jul; 28(7):676-82. PubMed ID: 19560695
[TBL] [Abstract][Full Text] [Related]
27. Hemodynamic response to sildenafil, nitric oxide, and iloprost in primary pulmonary hypertension.
Leuchte HH; Schwaiblmair M; Baumgartner RA; Neurohr CF; Kolbe T; Behr J
Chest; 2004 Feb; 125(2):580-6. PubMed ID: 14769741
[TBL] [Abstract][Full Text] [Related]
28. Pulmonary hemodynamic responses to brain natriuretic peptide and sildenafil in patients with pulmonary arterial hypertension.
Klinger JR; Thaker S; Houtchens J; Preston IR; Hill NS; Farber HW
Chest; 2006 Feb; 129(2):417-425. PubMed ID: 16478861
[TBL] [Abstract][Full Text] [Related]
29. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.
Michelakis ED; Tymchak W; Noga M; Webster L; Wu XC; Lien D; Wang SH; Modry D; Archer SL
Circulation; 2003 Oct; 108(17):2066-9. PubMed ID: 14568893
[TBL] [Abstract][Full Text] [Related]
30. Effects of chronic sildenafil use on pulmonary hemodynamics and clinical outcomes in heart transplantation.
Pons J; Leblanc MH; Bernier M; Cantin B; Bourgault C; Bergeron S; Proulx G; Morin J; Nalli C; O'Connor K; Chateauvert N; Sénéchal M
J Heart Lung Transplant; 2012 Dec; 31(12):1281-7. PubMed ID: 23127754
[TBL] [Abstract][Full Text] [Related]
31. Comparison of inhaled nitric oxide versus oxygen on hemodynamics in patients with mitral stenosis and severe pulmonary hypertension after mitral valve surgery.
Fernandes JL; Sampaio RO; Brandão CM; Accorsi TA; Cardoso LF; Spina GS; Tarasoutchi F; Pomerantzeff P; Auler JO; Grinberg M
Am J Cardiol; 2011 Apr; 107(7):1040-5. PubMed ID: 21296315
[TBL] [Abstract][Full Text] [Related]
32. Comparison of inhaled and intravenous milrinone in patients with pulmonary hypertension undergoing mitral valve surgery.
Wang H; Gong M; Zhou B; Dai A
Adv Ther; 2009 Apr; 26(4):462-8. PubMed ID: 19381522
[TBL] [Abstract][Full Text] [Related]
33. Sildenafil improves the beneficial haemodynamic effects of intravenous nitrite infusion during acute pulmonary embolism.
Dias-Junior CA; Montenegro MF; Florencio BC; Tanus-Santos JE
Basic Clin Pharmacol Toxicol; 2008 Oct; 103(4):374-9. PubMed ID: 18834358
[TBL] [Abstract][Full Text] [Related]
34. Long-term follow-up after conversion from intravenous epoprostenol to oral therapy with bosentan or sildenafil in 13 patients with pulmonary arterial hypertension.
Johnson RF; Loyd JE; Mullican AL; Fink CA; Robbins IM
J Heart Lung Transplant; 2007 Apr; 26(4):363-9. PubMed ID: 17403478
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetic and hemodynamic responses to oral sildenafil during invasive testing in children with pulmonary hypertension.
Apitz C; Reyes JT; Holtby H; Humpl T; Redington AN
J Am Coll Cardiol; 2010 Apr; 55(14):1456-62. PubMed ID: 20359596
[TBL] [Abstract][Full Text] [Related]
36. Effects of dipyridamole and inhaled nitric oxide in pediatric patients with pulmonary hypertension.
Ziegler JW; Ivy DD; Wiggins JW; Kinsella JP; Clarke WR; Abman SH
Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1388-95. PubMed ID: 9817684
[TBL] [Abstract][Full Text] [Related]
37. Does Sildenafil produce a sustained benefit in patients with pulmonary hypertension associated with parenchymal lung and cardiac disease?
Madden BP; Sheth A; Wilde M; Ong YE
Vascul Pharmacol; 2007; 47(2-3):184-8. PubMed ID: 17627899
[TBL] [Abstract][Full Text] [Related]
38. Oral sildenafil treatment for Eisenmenger syndrome: a prospective, open-label, multicentre study.
Zhang ZN; Jiang X; Zhang R; Li XL; Wu BX; Zhao QH; Wang Y; Dai LZ; Pan L; Gomberg-Maitland M; Jing ZC
Heart; 2011 Nov; 97(22):1876-81. PubMed ID: 21948962
[TBL] [Abstract][Full Text] [Related]
39. Hemodynamic effects of combination therapy with inhaled nitric oxide and iloprost in patients with pulmonary hypertension and right ventricular dysfunction after high-risk cardiac surgery.
Antoniou T; Koletsis EN; Prokakis C; Rellia P; Thanopoulos A; Theodoraki K; Zarkalis D; Sfyrakis P
J Cardiothorac Vasc Anesth; 2013 Jun; 27(3):459-66. PubMed ID: 23063102
[TBL] [Abstract][Full Text] [Related]
40. Therapy with sildenafil or bosentan decreases pulmonary vascular resistance in patients ineligible for heart transplantation because of severe pulmonary hypertension.
Perez-Villa F; Farrero M; Sionis A; Castel A; Roig E
J Heart Lung Transplant; 2010 Jul; 29(7):817-8. PubMed ID: 20363156
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
